Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TUMOR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05684432
What this trial is testing

Radiation-induced Diarrhoea During Curative EBRT of Prostate and Rectal Cancer

Who this might be right for
Radiation-induced Diarrhoea in Prostate and Rectal Cancer
Aalborg University Hospital 40
Not applicableStudy completedNCT00003598
What this trial is testing

UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia

Who this might be right for
Cervical CancerPrecancerous/Nonmalignant Condition
University of Michigan Rogel Cancer Center 180
Testing effectiveness (Phase 2)Ended earlyNCT06595563
What this trial is testing

HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer

Who this might be right for
HER2-positive Metastatic Breast CancerHER2-positive Advanced Breast Cancer
Jules Bordet Institute 87
Not applicableUnknownNCT04223063
What this trial is testing

Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility Study

Who this might be right for
Bladder CancerUrothelial Carcinoma
Ross Mason 20
Not applicableWithdrawnNCT05418387
What this trial is testing

A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in Arizona

Who this might be right for
Renal Cell CarcinomaHepatocellular Carcinoma
University of Arizona
Not applicableNot Yet RecruitingNCT05871593
What this trial is testing

CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01

Who this might be right for
Next-Generation-Sequencing
University Hospital Tuebingen 200
Very early researchWithdrawnNCT03591614
What this trial is testing

Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma

Who this might be right for
Monoclonal GammopathySmoldering MyelomaMyeloma
Case Comprehensive Cancer Center
Not applicableLooking for participantsNCT05189314
What this trial is testing

RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study

Who this might be right for
Thyroid Nodules
Columbia University 100
Testing effectiveness (Phase 2)Ended earlyNCT01090414
What this trial is testing

An Extension Study for Subjects Who Are Deriving Benefit With Idelalisib (GS-1101; CAL-101) Following Completion of a Prior Idelalisib Study

Who this might be right for
Chronic Lymphocytic LeukemiaLymphoma, Non-Hodgkin
Gilead Sciences 202
Large-scale testing (Phase 3)Active Not RecruitingNCT04736706
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 1,854
Testing effectiveness (Phase 2)Study completedNCT00101816
What this trial is testing

Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate

Who this might be right for
Chronic Myeloid LeukemiaBlast Crisis
Bristol-Myers Squibb 124
Large-scale testing (Phase 3)UnknownNCT01019616
What this trial is testing

Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy

Who this might be right for
Primary Breast Cancer
Tao OUYANG 400
Testing effectiveness (Phase 2)Study completedNCT01941316
What this trial is testing

Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients

Who this might be right for
Small Cell Lung CarcinomaNon Small Cell Lung CarcinomaIrinotecan Sensitive Cancers
Cancer Research and Biostatistics Clinical Trials Consortium 78
Large-scale testing (Phase 3)Looking for participantsNCT07627906
What this trial is testing

Ketofol Versus Ketodex for POD Prophylaxis in Elderly Cancer Surgery

Who this might be right for
Postoperative Delirium (POD)
Cairo University 180
Testing effectiveness (Phase 2)WithdrawnNCT03991104
What this trial is testing

SOX-based CRT for Esophageal Cancer.

Who this might be right for
Esophageal Cancer
Zhejiang Provincial People's Hospital
Early research (Phase 1)Looking for participantsNCT06340204
What this trial is testing

Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma

Who this might be right for
Ewing Sarcoma
Peking University People's Hospital 44
Not applicableLooking for participantsNCT07208084
What this trial is testing

Project SOAR (Speaking Our African American Realities) Awakenings for Black American Women Diagnosed With Breast Cancer

Who this might be right for
Breast Cancer
University of California, Los Angeles 90
Large-scale testing (Phase 3)Study completedNCT01974752
What this trial is testing

Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)

Who this might be right for
MetastaticUveal Melanoma
AstraZeneca 152
Testing effectiveness (Phase 2)UnknownNCT04893252
What this trial is testing

Vactosertib and Durvalumab in Gastric Cancer

Who this might be right for
Stomach Neoplasm
Hark Kyun Kim 55
Testing effectiveness (Phase 2)Looking for participantsNCT06465433
What this trial is testing

Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab

Who this might be right for
Hematologic Malignancies
Incyte Corporation 25
Next Page